Advertisement
Advertisement


Medical News

People With AIDS More Likely to Develop Cancers, Research Says

May 26, 2010

The cumulative incidence of non-AIDS-defining cancers (NADCs) is approaching that of AIDS-defining cancers among HIV patients in settings where antiretroviral therapy is common, according to a consortium of researchers. Their report will be presented at the 2010 American Society of Clinical Oncology Annual Meeting in Chicago June 4-8.

"We're seeing high rates of head and neck cancer, lung cancer, kidney cancer, liver cancer, and anal cancer," said John F. Deeken, the report's co-author and director of head and neck oncology at Georgetown University Medical Center. The study also found marked increases in Hodgkin's lymphoma.

"Even when we control for smoking, we see a higher rate than the general population," Deeken said. "We don't know why this is happening. We need to figure that out."

Advertisement
Deeken and colleagues have launched the first clinical trial to study interactions between antiretrovirals and chemotherapy, with the hope formulating treatment recommendations.

The high incidence of NADCs among HIV-infected people has been noted for years in separate studies. Activists say the availability of effective treatments has led some in high-risk populations to discount the danger of HIV; that perception might change if the virus began to be associated with cancer.

"The pills have side effects," said Robert Yarchoan, chief of the HIV and AIDS malignancy branch of the National Cancer Institute. "There's premature aging and heart attacks. And now there are these cancers."

Many doctors are not aware that HIV patients are more susceptible to NADCs, Yarchoan said. Until recently, HIV patients were excluded from clinical trials for NADCs because of their weakened immune systems, but the National Cancer Institute has led efforts to include them, he said.

To view the abstract, "Treating HIV+ Patients for Non-AIDS-Defining Cancers (NADCs) in the Era of Targeted Chemotherapy: An AIDS Malignancy Consortium Study of Sunitinib in Patients on ART," visit http://abstract.asco.org/AbstView_74_51819.html.

Back to other news for May 2010

Adapted from:
Washington Post
05.20.2010; Darryl Fears




This article was provided by CDC National Prevention Information Network. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update.
 

No comments have been made.
 

Add Your Comment:
(Please note: Your name and comment will be public, and may even show up in
Internet search results. Be careful when providing personal information! Before
adding your comment, please read TheBody.com's Comment Policy.)

Your Name:


Your Location:

(ex: San Francisco, CA)

Your Comment:

Characters remaining:

Advertisement